A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 102 participants.
Also called NCT07472725
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 102 participants
- Registry
-
NCT07472725
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07472725. Randomized; no masking; primary purpose treatment. Start 2026-04-11 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- SHR-3167 Injection
- Intervention (Drug)
- SHR-3167 Injection Placebo
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct07472725- Content hash
7a6a6f787a37a864a7e1794e5c4400864f45261aefeb7faacdcca63b6f68ae22